Breaking News

Biogen Appoints RED SVP

March 17, 2017

Ghosh will lead discovery and development efforts from idea through proof of concept

Anirvan Ghosh, Ph.D., has been appointed senior vice president, Research and Early Development (RED), Biogen. Dr. Ghosh will lead Biogen’s RED organization in the discovery and development of drug candidates from idea through proof of concept. He will report to Michael Ehlers, M.D., Ph.D., executive vice president, head of R&D.

Dr. Ghosh joins the company from E-Scape Bio, where he served as chief scientific officer, heading discovery efforts for Alzheimer’s disease and neurodegenerative disorders. Previously he served as vice president, global head of Neuroscience Discovery and Biomarkers at Roche, where he led research and drug discovery for programs addressing neurodegenerative diseases as well as neurodevelopmental and psychiatric disorders.

“We are excited to have Anirvan Ghosh join us at Biogen,” said Dr. Ehlers. “After an extensive global search, we have found an inspired leader to guide an exceptional Research and Early Development team. Anirvan is an accomplished neuroscientist and industry R&D leader who has delivered multiple novel drug candidates to the clinic.”